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ABSTRACT This work is a report on the development of a method of hybridization analysis on DNA microarrays for 
the simultaneous identification and typing of carbapenemase-encoding genes. These enzymes are produced by the 
microorganisms that are responsible for causing infectious diseases. The method involves several steps, including DNA 
extraction from clinical samples and amplification of carbapenemase genes by multiplex PCR with simultaneous la-
belling by biotin. Following that, hybridization of the labeled PCR products with oligonucleotide probes immobilized 
on the surface of a nitrocellulose-based DNA microarray occurs. The biotin molecules attached to the DNA duplexes 
are detected by using conjugates of streptavidin-horseradish peroxidase, which is then quantified by colorimetric 
detection of the enzyme. We have designed the required oligonucleotide probes and optimized the conditions of the 
membrane microarray-based hybridization analysis. Our method allows to identify 7 types of carbapenemase genes 
belonging to the molecular classes A, B, and D, and it also allows additional typing into genetic subgroups. The micro-
arrays have been tested with the control strains producing the carbapenemase genes which have been characterized 
by sequencing. The developed method of hybridization analysis was employed to investigate clinical strains of Pseu-
domonas spp. and Acinetobacter spp., which produce carbapenemases of different classes based on phenotypic testing. 
All strains of Acinetobacter baumanii resistant to carbapenems were producers of two carbapenemase OXA-type genes 
(OXA-51, in combination with OXA-23 (1 strain), OXA-40 (5 strains), or OXA-58 (4 strains)). The metallo-β-lactamase 
VIM-2 type gene was detected in all Pseudomonas aeruginosa strains resistant to carbapenems. Testing of carbapenem-
sensitive strains did not detect any carbapenemase genes. The microarray method for the identification of carbapen-
emase genes is very accurate and highly productive. It can be employed in clinical microbiological laboratories for the 
identification and study of carbapenemase epidemiology.
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INTRODUCTION
During the last 20 years β-lactam antibiotics have been 
one of the drugs of choice for the treatment of a wide 
range of severe infectious diseases caused by gram-
negative microorganisms. Among these antibiotics, car-
bapenems are one of the most successful drug groups 
(chemical structure shown in Fig. 1). This group of an-
tibiotics is characterized by a wide spectrum of sensi-
tive organisms, low toxicity, and good pharmacokinet-
ics [1]. However, their efficiency has recently begun to 
show limitations with the emergence of drug-resistant 
strains. Carbapenem-resistant strains are most often 
found among nosocomial (in-hospital) infections be-
longing to the Pseudomonas spp. and Acinetobacter spp. 
genera. Healthcare facilities in the Russian Federation 
are, for example, noting a considerable increase in the 
number of pathogens resistant to carbapenem treat-
ment. 38% of the observed Pseudomonas aeruginosa 
strains are now resistant to these drugs [2]. 
The emergence of β-lactam resistance in gram-nega-
tive bacteria can happen through several mechanisms, 
which include alteration of membrane permeability 
due to defective porine channels [3, 4],  or activation of 
efflux systems [5]. However, the most clinically and epi-
demiologically important mechanism is the production 
of bacterial enzymes β-lactamases which hydrolyze the 
β-lactam ring of the antibiotic drug - β-lactamases [6, 
7]. The β-lactamases are currently divided into 4 mo-
lecular classes – А, B, C, and D, based on their primary 
structure. The А-, C- and D-class enzymes are serine-
type hydrolases, while the B-class enzymes are metal-
lo-hydrolases, which bear one or two zinc atoms in their 
active site [8]. Several molecular classes of β-lactamase 
possess carbapenemase activity: however, the most of-
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ten found and clinically important carpbapenemases 
are KPC-type A-class enzymes [9], 5 groups of metallo-
β-lactamases (VIM, IMP, SPM, GIM, SIM) [10], and a 
number of OXA-type D-class enzymes (subgroups 
OXA-23, OXA-40, OXA-51, OXA-58) [11]. 
Of all the numerous β-lactamases, carbapenemases are 
the most dangerous; they display high catalytic activity 
and wide substrate specificity, which includes practically 
every class of β-lactam antibiotics. Since carbapenemase-
encoding genes are located on a plasmid, they can spread 
among pathogenic microorganisms at a rapid pace. Be-
cause of the variety of carbapenemases and the danger 
of their spreading, there is a need for robust methods for 
the detection of enzyme production, which can then be 
used for choosing the best suited treatment and for epi-
demiological control over the spreading of specific drug-
resistant types. This is currently accomplished by using 
microbiological tests [6, 12, 13]. However, these tests take 
time and are ineffective for the identification of carba-
penemase types. Identification of ОХА-type enzymes by 
phenotype-based tests is virtually impossible [14].
Several PCR-based methods have been suggested 
for the identification of metallo-β-lactamase genes of 
the most spread VIM and IMP types [15, 16], and the 
main ОХА-type carbapenemase subgroups [17]. A 
method for the identification of 5 groups of metallo- 
β-lactamases, involving multiplex real-time PCR with 
subsequent analysis of the melting curves of the ob-
tained amplicons, has recently been developed [18]. 
However, the multiplex capacity of PCR is usually lim-
ited, which makes simultaneous detection of a large 
number of genes impossible. 
Hybridization analysis based on a microarray-tech-
nology is a promising method of identification that 
yields quick results of high informative value. This 
technique has considerable advantages over tradition-
al methods, since it allows a multi-parametric analysis 
and also uses a miniscule sample, which reduces cost 
and the time needed to obtain results [19, 20].
 The goal of this work was to develop a method for 
the identification of A-, B-, and D-class carbapenemase 
genes involving hybridization analysis on membrane-
based DNA microarrays which could be visualized by 
colorimetric detection. 
EXPERIMENTAL PROCEDURES
The collection of primers for the amplification of car-
bapenemase genes and the amino-modified oligonu-
cleotide probes were synthesized by Synthol (Moscow, 
Russia). Samples of the bacterial DNA extracted from 
control strains of A. baumanii, Ps. aeruginosa, Es-
cherichia coli, and Klebsiella pneumonia were provided 
by the Institute of Antimicrobial Chemotherapy of the 
Smolensk State Medical Academy. These samples pro-
duced carbopenemases VIM-1, VIM-2, VIM-4, VIM-
7, IMP-1, IMP-2, SPM-1, OXA-23, OXA-40, OXA-51, 
OXA-58, and KPC-3. Cell cultures of microorganisms 
from the Enterobacteriaceae family and A. baumanii 
and Ps. aeruginosa strains, either sensitive or resist-
ant to carbapenems, according to phenotypic tests per-
formed on a VITEK automatic analyzer (BioMerieux, 
France), were provided by the Burdenko Institute of 
Neurosurgery. 
Bacterial DNA extraction
Extraction of bacterial DNA from a cell suspension with 
no less than 105 CFU/ml was performed using temper-
ature lysis in a buffer. 500 µl of suspension was placed 
in centrifuge tubes, and the cells were pelleted by cen-
trifugation at 10,000 g for 1 minute. After removing the 
supernatant, 100 µl of buffer (10 мМ Tris-HCl, 1 мМ 
EDTA, рН 7.5) was added to the pellet, which was then 
re-suspended with a shaker. The tubes were then incu-
bated on a solid-medium thermostat for 20 minutes at a 
temperature of 990 С. After heating, the samples were 
centrifuged for 1 minute at 10,000 g. A PCR sample 
used 1 µl of the obtained supernatant. 
Amplification of carbapenemase genes using multiplex 
PCR with simultaneous biotin labeling
Amplification of carbapenemase (A-, B-, and D-class) 
gene-fragments, with simultaneous biotin labeling, was 
performed in two multiplex PCR reactions (one reac-
tion amplified the genes of all the metallo-β-lactamases 
and the other amplified the  ОХА- and КРС-type 
β-lactamase genes). Each multiplex PCR sample was 
25 µl in volume and contained the following: 10 mМ 
Tris-НСl-buffer with 2.5 mМ of magnesium acetate, 50 
mМ KCl рН 8.3, 2.5 units of Taq-DNA-polymerase, 100 
µМ dATP, dGTP, dCTP, 60 µМ dTTP, 40 µM dUTP-
11-biotin (Fermentas, Germany), 0.4 µМ each of the 
direct and reverse primer for each group of carbap-
enemase, and 1 µl of the template DNA solution. Am-
plification was performed in a Mastercycler gradient 
amplifier (Eppendorf, Germany) according to the fol-
lowing protocol: initial denaturation at 94˚С (2 min), 25 
cycles of amplification (20 sec – denaturation at 94˚С, 
30 sec – annealing of the primers at 65°С, 1 minute – 
elongation at 72˚С), and a final elongation step at 72˚С 
Fig. 1. Chemi-
cal structure of 
carbapenemes. 
β-Lactam ring in 
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(6 min). Horizontal electrophoresis of the PCR products 
was performed in a 1% agarose gel with ТАЕ buffer 
(40 mМ Тris, 20 mМ acetic acid, 1 mМ EDTA, рН 8.5) 
with etidium bromide added to a final concentration of 
1.6 µg/ml. Visualization was performed on a UV-tran-
silluminator at a wavelength of 260 nm.
Fragmentation of the PCR-products
The DNA was fragmented at room temperature for 5 
minutes. Amplified DNA was diluted to a concentra-
tion of 30 ng/microliter with the reaction buffer (40 mМ 
Tris-HCl, 10 mМ MgSO4, 1 mМ CaCl2, pH 8.0), and the 
mixture was then supplemented with DNAase I (Pro-
mega, Germany). The reaction was stopped by the addi-
tion of 3 mМ EDTA and 10-minute incubation at 65˚С.
Immobilization of the oligonucleotide probes on a 
membrane-based DNA-microarray
BioTrace NT nitrocellulose (Pall Corporation, USA) was 
used as a support for DNA-microarray. Modification of 
the membranes was performed according to [21], using 
1-ethyl-3-(3-dimethylaminopropyl)carboimide (Sigma, 
USA). The oligonucleotides were diluted in a buffer 
(160 mМ Na2SO4, 130 mМ Na2HPO4) to a final concen-
tration of 20 µМ and then applied onto the membranes 
by an XactIITM Arrayer robot (LabNEXT Inc., USA) us-
ing 300 µm pins. After the procedure, the membranes 
were incubated at 60˚С for 30 minutes.
Hybridization on the DNA microarray
Prior to hybridization, the microarrays were washed 
with PBST buffer (0.01 М К2НРО4, 0.15 М NaCl, 0.05% 
Tween-20, рН 7.0) twice, 10 minutes each time at room 
temperature, and then blocked in a solution of 1% bo-
vine serum albumine (BSA) and  1% casein (Sigma, 
USA) in PBS buffer (0.01 М К2НРО4, 0.15 М NaCl, рН 
7.0) at 37˚С for 30 minutes. 500 ng of fragmented and la-  for 30 minutes. 500 ng of fragmented and la-
beled DNA was then diluted in the hybridization buffer 
- 2х SSPE (0.3 М NaCl, 0.02 М NaH2PO4, 2 mМ EDTA, 
рН 7.4), which also included 1.6 pmol/ml of the control 
biotin-labeled oligonucleotide (positive hybridization 
control). The microarray was then placed into the hy-
bridization mixture (300 µl per 1 array) and incubated 
at 45˚С for 1 hour in a Thermomixer comfort apparatus 
(Eppendorf, Germany). After hybridization, the mem-
branes were washed with PBST twice for 15 minutes at 
room temperature. 
Detection and hybridization data analysis
The microarrays were incubated in a solution of 
streptavidine-peroxidase conjugate (Imtek, Russia) 
(0.2 µg/ml) in PBST for 30 minutes at 37˚С. Then they 
were washed in PBST for 10 minutes and placed into a 
substrate solution containing 3,3´,5,5´-tetramethylben-
zydene (TMB), Н2О2 (NVO Immunotech, Russia) and 
sodium dextransulphate (Mr = 8000, Pharmacia, Swe-
den) (final concentration - 0.5% (by mass)) for 10 min-
utes, after which the arrays were washed in distilled 
water and air-dried. The membrane microarrays were 
scanned on a Perfection V750 Pro (Epson, Germany) 
scanner at a resolution of 4,800 dpi. The obtained im-
ages (in TIFF format) were analyzed using Scan Array 
Express (PerkinElmer, version 3.0, Germany) software, 
and the intensity values of the analytic signals at vari-
ous spots of the microarray were determined. The ab-
solute values of the signals were then recalculated into 
relative signals, using the mean intensity of the positive 
hybridization control used in each array. 
RESULTS AND DISCUSSION
Molecular design of the oligonucleotide probes
The Genbank database currently has information on 
10 KPC-type enzymes, 52 metallo- β-lactamases (23 
from the IMP group, 26 from the VIM group and one 
member of each of the following groups - SPM, SIM 
and GIM), and also 70 carbapenemases from the ОХА 
group. Alignment of the amino acid and encoding se-
quences of these enzymes shows that only enzymes 
from the KPC group display a high degree of similarity 
within their group (differ by 1-2 amino acid substitu-
tions), while the numerous members of the IMP, VIM, 
and OXA groups differ considerably  from their group 
members. Because of this, each group was split into sep-
arate subgroups, which included enzymes whose genes 
were highly similar. Thus, the VIM group was divided 
into 3 subgroups (VIM-1, VIM-2, and VIM-7); the IMP 
group, into 6 subgroups (IMP-1, IMP-2, IMP-5, IMP-
11, IMP-12, and IMP-14); while carbapenemases from 
the OXA groups were divided into 4 subgroups (ОХА-
23, OXA-40, OXA-51 and OXA-58). Group and sub-
group classification of carbapenemases based on their 
amino acid sequence alignments and their β-lactamase 
molecular classification are shown in Fig. 2. 
One of the main stages of DNA microarray develop-
ment was the design of the oligonucleotide probe se-
quences required to detect various groups of carbapen-
emase genes. The selection of an oligonucleotide probe 
for the identification of a group of genes is based on the 
alignment of the coding sequences of all the carbapene-
mase genes in this group. What is needed is a sufficiently 
long fragment of the gene that is conserved in all of the 
members of this group and is no less than 18 nucleotides 
long. These regions were then analyzed in terms of melt-
ing temperature, G/C content and secondary structure 
formation. In order to perform microarray-based hy-
bridization analysis, we selected the oligonucleotides 
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whose melting temperature differed by no more than 
10°С. Based on the selected sequences, we synthesized 
two oligonucleotide probes which were complementary 
to the direct and reverse strands of the gene. For ad-
ditional typing of IMP, VIM, and ОХА carbapenemase 
gene-subgroups, we chose regions with high similarity 
which bore no mutations inside a given subgroup and 
had low similarity with genes from other subgroups. In 
order to increase the specificity of the analytical pro-
cedure, we chose two oligonucleotide probe variants 
which corresponded to different regions of the gene. In 
this case, we synthesized the probes which were comple-
mentary to the reverse strand of the gene. 
The sequence of the chosen oligonucleotide probes 
and their characteristics are presented in Table 1. The 
length of the probes varied from 18 to 27 nucleotides, 
the G/C-content was 30- 60%, and the melting temper-
ature was 63–72°С. Each probe was supplemented by 
additional spacers at the 5’-terminus, which helped to 
distance the probe from the array surface, thus remov-
ing steric barriers for hybridization and increasing the 
availability of the probe for the DNA-target. Optimiza-
tion procedures showed that the best spacer contained 
13 thymidine residues. The additional thymidines did 
not have any significant effects on the intensity of the 
hybridization signals, or on the specificity of hybridiza-
tion (data not shown).
Amplification of carbapenemase genes of various mo-
lecular classes with simultaneous labeling
Amplification of A-, B-, and D-class carbapenemase 
genes utilized multiplex PCR with simultaneous bio-
tin labeling. Biotin-labeled deoxyribouridine triphos-
phate (dUTP) was used as a labeling reagent and was 
incorporated into the DNA, along with unlabeled de-
oxyribothymidine triphosphate (dTTP). The templates 
for the PCR reaction were bacterial DNA samples 
extracted from the control strains of microorganisms 
producing β-lactamases VIM-1, VIM-2, VIM-7, IMP-1, 
IMP-2, SPM-1, OXA-23, OXA-40, OXA-51, OXA-58, 
and KPC-3. 
Design of primers for the amplification of various 
carbapenemase genes was based on an alignment of 
the coding regions of these genes. Primers for ampli-
fication of the full-size carbapenemase genes from the 
KPC group and metallo-β-lactamase groups SPM, SIM, 
and GIM were chosen from regions which were con-
served in this group, namely the gene termini. We could 
not find conserved regions longer than 20 bp for met-
allo- β-lactamases from the IMP and VIM groups, nor 
could we find any for OXA-type carbapenemases, since 
these groups showed a low degree of in-group similar-
ity, which is why separate primers had to be selected 
for each subgroup. 
The length of the primers (20 – 28 nucleotides) was 
chosen so as to push their melting temperature to 62 – 
680С, which would allow simultaneous amplification of 
all the types of genes simultaneously and with equal ef-
ficiency. Primer selection also factored in G/C-content, 
and we chose structures that had a G/C content of 30 – 
60%. We also estimated the possibility of primer-dimer 
and secondary structure formation and favored the 
sequences which were least likely to do so. As a result, 
each group was fitted with several direct and reverse 
primers with various parameters. Various combinations 
of these primers were tested in PCR reactions in order 
β-Lactamases
Serine Metalloenzymes (Zn2+)
Molecular classes  
of enzymes А В С D
Groups of  
carbapenemases KPC OXA IMP SPM VIM SIM GIM
Subgroups of  
carbapenemases
OXA-23
OXA-40
OXA-51
OXA-58
IMP-1
IMP-2
IMP-5
IMP-11
IMP-12
IMP-14
VIM-1
VIM-2
VIM-7
Fig. 2. Classification 
of carbapenemases 
into groups and 
subgroups based 
on the alignment of 
amino acid se-
quences and their 
correspondence to 
molecular classes of 
β-lactamases. RESEARCH ARTICLES
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to test the specificity of gene amplification. The primers 
which showed the highest specificity with a good out-
put were used for the multiplex procedure. The primer 
sequences are presented in Table 2.
In order to determine the optimal primer-anneal-
ing temperature for the multiplex amplification of all 
the carbapenemase gene types, we first calculated the 
optimal annealing temperature for each pair of prim-
ers in a specific reaction and then selected the lowest 
temperature value for the multiplex PCR reaction. The 
range of the studied primer Та ‘s was 52 – 68оС. The 
optimal Та turned out to be 60ºС. Reactions at this tem- . Reactions at this tem-
perature resulted in the efficient synthesis of specific 
PCR-products. 
After determining the optimal carbapenemase gene 
amplification conditions, we evaluated the possibility of 
performing multiplex PCR with 16 pairs of primers in 
order to amplify the genes of all of the studied groups 
simultaneously. However, under these conditions the 
specific product for most of the carbapenemase groups 
was either absent or the yield was very low, which made 
further microarray hybridization analysis impossible. 
Because of this, we decided to amplify the carbapen-
emase genes using a two step multiplex PCR procedure: 
the first used a mixture of primers specific to metallo-β-
lactamases (11 pairs of primers), and the second used a 
mixture of primers specific to ОХА and КРС carbapene- ОХА and КРС carbapene-  and КРС carbapene- КРС carbapene-  carbapene-
mases (5 pairs of primers). The results of electrophoretic 
analysis of the PCR-products obtained during the am-
plification of various carbapenemase genes from control 
microorganism strains are presented in Fig. 3.
The yield of labeled specific products from the mul-
tiplex PCR procedure was approximately 40-50 ng/µl 
for each type of carbapenemases gene, which was suffi-
cient for further microarray-based hybridization anal-
ysis. Amplification of nonspecific products was detected 
only for genes from the VIM-1 and VIM-2 subgroups: 
however, these products had low yields and, as it fol-
lows from later experiments, their presence did not af-
fect the specificity of the hybridization analysis. 
Oligonucleotide microarray for detecting A-, B-, and 
D-class carbapenemase genes 
The DNA microarray for the identification of the ma-
jor types of carbapenemases is made on a support of   
nitrocellulose and has a size of 6.0 х 9.5 mm. On its sur- х 9.5 mm. On its sur-  9.5 mm. On its sur-
face there are 40 immobilized oligonucleotide probes 
(14 probes for the identification of 7 distinct groups of 
carbapenemases and 26 probes for additional typing 
of these genes into subgroups). Each microarray also 
includes 3 types of control oligonucleotides: an immo-
bilization control (a biotin labeled oligonucleotide), a 
positive hybridization control (an oligonucleotide whose 
sequence is complementary to a biotin-labeled oligonu-
cleotide which is added to the hybridization mixture), a 
negative hybridization control (an oligonucleotide with 
a random base sequence). In order to increase the re-
producibility of this procedure, each oligonucleotide 
probe is present on the microarray in three copies. A 
schematic of the layout of the specific and control oligo-
nucleotide probes on the surface of the DNA microar-
ray is presented in Fig. 4. 
The carbapenemase gene identification procedure 
involved hybridization analysis on a DNA microarray 
and included the following stages: 1) amplification of 
the β-lactamase gene from DNA isolated from the clini-
cal strain (by two multiplex PCR reactions); 2) hybrid-
ization of the biotin-labeled DNA with oligonucleotide 
probes on the surface of the microarray; 3) visualization 
of the hybridization results using a streptavidin-per-
oxidase conjugate followed by colorimetric detection 
of the enzyme.
We also optimized hybridization conditions. We ana-
lyzed hybridization efficiency at temperatures rang-
ing from 40 to  50°С; the temperature could not be 
higher than the melting temperature (Tm) of any oli-
gonucleotide probe and was limited by the high level 
of nonspecific hybridization at lower temperatures. 
Hybridization at 40°С displayed strong signals: how- С displayed strong signals: how-  displayed strong signals: how-
ever, most of the probes showed cross-hybridization 
with the genes of various carbapenemases. Hybridiza-
а b KPC-3  OXA-23  OXA-40  OXA-51 OXA-58  Markers
2000 2000
1000 1000
1500 1500
750 750
500 500
250
250
VIM-1  VIM-2  VIM-7  IMP-1  IMP-2  SPM-1  Markers
Fig. 3. Electrophoretic separation of multiplex PCR products after amplification of OXA-, KPC-type carbapenemases (a) 
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Table 1. Sequences of the specific and control oligonucleotide probes
Name Nucleotide sequence, 5’→3’ Length, 
nucleotides
G/C,
%
Тm
°С
Control oligonucleotides
Immobilization control TCTAGACAGCCACTCATA-Biotin 18 44.4 60.4
Positive hybridization control GATTGGACGAGTCAGGAGC 19 57.9 66.1
Negative hybridization control TCTAGACAGCCACTCATA 18 44.4 60.4
Oligonucleotide probes for determining the carbapenemase group
KPC_direct GCTTCCCACTGTGCAGCTCATTC 23 56.5 72.0
KPC_reverse GAATGAGCTGCACAGTGGGAAGC 23 56.5 72.0
VIM_direct GGAGATTGAAAAGCAAATTGGACT 24 37.5 66.6
VIM_reverse AGTCCAATTTGCTTTTCAATCTCC 24 37.5 66.6
IMP_direct GGAATAGAGTGGCTTAATTCTCG/A 23 41.3 64.7
IMP_reverse C/TGAGAATTAAGCCACTCTATTCC 23 41.3 64.7
SPM_direct GATGGGACCGTTGTCATTG 19 52.6 64.9
SPM_reverse CAATGACAACGGTCCCATC 19 52.6 64.9
SIM_direct CCTTGGCAATCTAAGTGACGCAA 23 47.8 69.7
SIM_reverse TTGCGTCACTTAGATTGCCAAGG 23 47.8 69.7
GIM_direct CACACTGGGAAATGGGCTTATA 22 45.5 66.7
GIM_reverse TATAAGCCCATTTCCCAGTGTG 22 45.5 66.7
OXA_direct CCACAA/GGTG/AGGC/TTGGTTG/AAC 20 55.0 67.0
OXA_reverse GTC/AAACCAG/ACCC/TACT/CTGTGG 20 55.0 67.0
Oligonucleotide probes for determining the carbapenemase sub-group
VIM-1_568 TCAGCGAACGTGCTATACGG 20 55.0 68.3
VIM-1_590 GTTGTGCCGTTCATGAGTTGT 21 47.6 67.9
VIM-2_568 TCTGCGAGTGTGCTCTATGG 20 55.0 67.9
VIM-2_590 GTTGTGCGATTTATGAGTTGT 21 38.1 63.7
VIM-7_127 GTTCGGCTGTACAAGATTGGCG 22 54.5 70.0
VIM-7_181 CTCGGTGACACGGTGTAC 18 61.1 65.8
IMP-1_135 GTGGGGCGTTGTTCCTAAACATG 23 52.2 70.2
IMP-1_387 GGTTCAAGCCACAAATTCATTTAGC 25 40.0 67.8
IMP-2_264 TCAAAGGCACTATTTCCTCACATTTC 26 38.5 68.2
IMP-2_497 TACCTGAAAAGAAAATTTTATTCGGTG 27 29.6 65.7
IMP-5_506 AATAGAGTTTTGTTCGGTGGTT 22 36.4 65.0
IMP-5_459 TGGTCCAGGGCACACTCC 18 66.7 70.4
IMP-11_570 TGTTGAAGCATGGCCACATT 20 45.0 67.6
IMP-11_621 TGCAAAACTGGTTGTTCCAAGCC 23 47.8 70.9
IMP-12_226 AAATTAGTTGCTTGGTTTGTAGGG 24 37.5 66.4
IMP-12_495 GCTACCTGAAAACAAAATTTTATTCG 26 30.8 64.8
IMP-14_292 GGTGACAGTACGGCTGGAATAG 22 54.5 68.4
IMP-14_374 AAAAAGACAATAAGGTACAAGCTA 24 29.2 63.4
OXA-23_225 AAATACAGAATATGTGCCAGCCTCT 25 40.0 68.8
OXA-23_309 GAAGGGCGAGAAAAGGTCATTTAC 24 45.8 68.0
OXA-40_225 AAATAAAGAATATGTCCCTGCATCA 25 32.0 65.6
OXA-40_329 GAACTTATCCTATGTGGGAGAAAG 24 41.7 64.8
OXA-51_225 TTCGACCGAGTATGTACCTGCTTCG 25 52.0 71.7
OXA-51_578 GCCCAAAAGTCCAAGATGAAG 21 47.6 65.8
OXA-58_225 AAAAACAGCTTATATTCCTGCATCT 25 32.0 66.0
OXA-58_206 GCACGCATTTAGACCGAGC 19 57.9 67.7RESEARCH ARTICLES
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Table 2. Primer sequences for the multiplex PCR-amplification of carbapenemase genes 
Type Sequence 5’→3’ Length, 
nucleotide
G/C,
%
Тm,
°С
Length of  
PCR-product, bp
KPC
direct TTCTGCTGTCTTGTCTCTCATGG 23 47.8 64.7
801 
reverse CCTCGCTGTGCTTGTCATCC 20 60.0 65.7
IMP-1
direct GGCGTTTATGTTCATACTTCGTTTG 25 40.0 64.4
584 
reverse GTAAGTTTCAAGAGTGATGCGTCTCC 26 46.2 65.6
IMP-2
direct GGTGTTTATGTTCATACATCGTTCG 25 40.0 63.8
584 
reverse GTACGTTTCAAGAGTGATGCGTCCCC 26 53.8 67.8
IMP-5
direct GGTGTTTATGTTCATACTTCGTTTG 25 36.0 62.5
584 
reverse GTACGTTTCAAGAGTGATACATCTCC 26 42.3 63.4
IMP-11
direct GGTGTTTATGTTCATACATCGTTTG 25 36.0 62.6
584 
reverse GTAAGCTTCAAGAGCGACGCATCTCC 26 53.8 67.8
IMP-12
direct GGTGTTTATCTTCATACATCTTTTG 25 32.0 60.5
584
reverse GTAAGTTTCAAGAGTGATGCGTTCCC 26 46.2 66.0
VIM-1
direct GTAGTTTATTGGTCTACATGACCGCGTC 28 46.4 66.9
743 
reverse CGCTGTGTGCTGGAGCAAGTC 21 61.9 68.1
VIM-2
direct GTAAGTTATTGGTCTATTTGACCGCGTC 28 42.9 65.9
743 
reverse CGTTGTGTGCTTGAGCAAGTC 21 52.4 64.7
VIM-7
direct AGCATATTCCGCACAGCCTGG 21 57.1 67.5
685 
reverse CCGGGCGGTCTGGAATTGCTC 21 66.7 67.7
SPM
direct CGTTTTGTTTGTTGCTCGTTGCGGG 25 52.0 67.4
648 
reverse CCTTCACATTGGCATCTCCCAGATAAC 27 48.1 67.2
SIM
direct GTTTGCGGAAGAAGCCCAGCC 21 61.9 68.6
613 
reverse CTCCGATTTCACTGTGGCTTGGG 23 56.5 67.6
GIM
direct CTTGTAGCGTTGCCAGCTTTAGCTC 25 52.0 67.8
638 
reverse CTGAACTTCCAACTTTGCCATGCC 24 50.0 66.9
OXA-23
direct GAAACCCCGAGTCAGATTGTTCAAG 25 48.0 65.8
686
reverse GGCATTTCTGACCGCATTTCC 21 52.4 64.8
OXA-40
direct GTTTCTCTCAGTGCATGTTCATC 23 43.5 62.3
714 
reverse CATTTCTAAGTTGAGCGAAAAGGGG 25 44.0 64.6
OXA-51
direct CGAAGCACACACTACGGGTG 20 60.0 65.4
649 
reverse CTCTTTTCGAACAGAGCTAGGTATTC 26 42.3 63.4
OXA-58
direct CTTGTGCTGAGCATAGTATGAGTC 24 45.8 63.3
684 
reverse CCACTTGCCCATCTGCCTTTTC 22 54.5 66.5
Table 3. Results on clinical sample testing on DNA microarrays
Type  
of microorganism
Carbapenemase sensitivity as 
determined by phenotypical tests
Number of 
samples
Detected carbapenemase types
OXA-23 OXA-40 OXA-51 OXA-58 VIM-2
A. baumanii
Resistant
10 1 5 10 4 -
Ps.aeruginosa 11 - - - - 11
A. baumanii
Sensitive
2 - - - - -
K. pneumonia 3 - - - - -
E. coli 2 - - - - -108 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
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Immobilization control
Positive hybridization control
Negative hybridization control
Probes for identification genes of metallo-β-lactamases
Probes for identification genes of OXA-type carbapenemases
Probes for identification genes of KPC-type carbapenemases
IMP-1
IMP-2
IMP-5
IMP-11
IMP-12
IMP-14
ID_IMP
VIM-1
VIM-2
VIM-7
ID_SPM
ID_SIM
ID_GIM
ID_VIM
OXA-23
OXA-40
OXA-51
OXA-58
ID_KPC
ID_OXA
Fig. 4. Layout of specific and 
control oligonucleotide probes 
on the surface of the DNA micro-
array for the identification of the 
A-, B-, D-class carbapenemase 
genes. 
tion at 50°С displayed weak signal intensities for some 
of the probes. For these reasons, we chose 45°С as the 
optimal temperature. The hybridization buffer con-
sisted of 2х SSPE supplemented by 0.2 % sodi dodecyl- х SSPE supplemented by 0.2 % sodi dodecyl-  SSPE supplemented by 0.2 % sodi dodecyl-
sulphate (SDS) in order to improve the membrane’s 
wetting properties. 
The size of the labeled DNA-target proved to be a 
critical parameter for hybridization. Hybridization of 
labeled PCR-products whose size was 580–800 nu-
cleotides with the appropriate oligonucleotide probes 
proved to yield weak signals. Additional fragmentation 
by DNAase (yielding fragments of 50–150 nucleotides) 
proved to increase hybridization signal intensity for 
most of the probes. 
Hybridization duration was assayed within a range 
of 0.5 to 4.0 hours. It was observed that the hybridiza-
tion of biotin-labeled DNA onto immobilized probes 
reaches equilibrium after two hours of incubation with 
active mixing. We also noticed that conducting the re-
action in kinetic conditions (1 hour) does not dramati-
cally weaken the signals as compared to the equilibrium 
state (about 10 – 20% depending on the probe). It also 
did not lower the specificity of the analytic procedure, 
which allowed the positive identification of all types of 
carbapenemase genes in the hybridization mixture. 
Figure 5 shows the results of an experiment in 
which control microorganism strains producing VIM-1 
and IMP-1 metallo- β-lactamases and carbapenemases 
OXA-51 and ОХА-40 were tested on our DNA microar- ОХА-40 were tested on our DNA microar- -40 were tested on our DNA microar-
ray. Identification of the β-lactamase group was assayed 
by the hybridization intensity with a group-specific 
probe, while additional typing was assayed by the hy-
bridization intensity with subgroup-specific probes. The 
advantage of the microarray-based hybridization analy-
sis is the possibility of simultaneously detecting several 
genes, which is demonstrated by testing the control A. 
baumanii strain for ОХА-type carbapenemases. 
Testing clinical strains of microorganisms resistant to 
carbapenems
The DNA microarray developed was tested on clini-
cal strains of gram-negative microorganisms, either 
resistant or sensitive to carbapenems, as assayed by 
a phenotypical test. Table 3 shows the results for 28 
clinical strains of Ps. aeruginosa, A. baumanii and En-
terobacteriaceae spp., which display various levels of 
carbapenem sensitivity (strains were provided by the 
N.N. Burdenko Institute of Neurosurgery and Institute 
of Antimicrobial Chemotherapy of Smolensk State 
Medical Academy). All the A. baumanii strains which 
proved resistant to carbapenems (as assayed by pheno-
typing) expressed two carbapenemase genes (ОХА-51 
and ОХА-23 (1 strain), ОХА-40 (5 strains), ОХА-58 (4 
strains)). All the carbapenem-resistant Ps. aeruginosa 
strains happened to possess a VIM-2-type metallo-
β-lactamase gene. Testing of carbapenem-sensitive RESEARCH ARTICLES
 VOL. 2  № 3 (6)  2010  | ACTA NATURAE | 109
strains revealed no carbapenemase genes. Thus, the 
results of the microarray-based hybridization analysis 
are in accordance with the phenotyping tests. More-
over, the structure of the observed carbapenemases 
was confirmed by gene sequencing for two carbapen-
em-resistant samples - one strain of A. baumanii and 
one strain of Ps. aeruginosa, which expressed ОХА-40, 
ОХА-51 and VIM-2 genes.
Thus, our method of hybridization analysis based on 
DNA microarray for the identification and typing of 
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Fig. 5. Results of a DNA microarray-based hybridization 
analysis for control Ps. aeruginosa (a, b) and A. baumanii 
(c) strains, producing carbapenemases VIM-1 (a), IMP-
1(b), OXA-51 and OXA-40 (c).
carbapenemase genes is highly accurate, productive, 
and can be used in clinical microbiological laboratories 
for the identification of carbapenemases and for study-
ing their epidemiology. The phenotyping tests currently 
being used take time (from 24 to 48 hours) and are not 
always effective for determining carbapenemase types, 
such as ОХА-type carbapenemases. Identification of 
carbapenemase genes on DNA microarrays allows rap-
id diagnostics, with the whole procedure taking only 
4.5 hours, including 0.5 hours for bacterial DNA extrac-
tion, 1.5 hours for amplifying the carbapenemase genes 
and fragmenting the PCR-products, 1.5 hours for the 
hybridization and washing steps, and 1 hour for colori-
metric detection of the hybridization results. An impor-
tant feature of this method is the possibility of simulta-
neously identifying several genes in one sample. 
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